Product Information
TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.7019 per EA under NDC 60505388207. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Mar 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Apotex Corp.NDC
60505388207
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TETRABENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA206093FDA Approved
3/17/2020
TE Code
AB
On Market Since
6/18/2020
Pharmacological Classes
Price Statistics
The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7019 per EA |
|---|---|
| All-time high | $3.2465 (Dec 13, 2023) |
| All-time low | $0.7019 (Sep 23, 2026) |
| 52-week high | $0.8066 |
| 52-week low | $0.7019 |
| Median price | $1.4241 |
| Average price | $1.6502 |
| Largest weekly change | -63.3% (Dec 20, 2023) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tetrabenazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vesicular Monoamine Transporter 2 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Apotex Corp., is $0.7019 per EA (NDC 60505388207), effective Sep 30, 2026.
How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 72.9%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?
Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.7019 (Sep 23, 2026) to a high of $3.2465 (Dec 13, 2023), with a median of $1.4241 per EA.
Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TETRABENAZINE 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TETRABENAZINE 12.5 MG TABLET?
TETRABENAZINE 12.5 MG TABLET (NDC 60505388207) is labeled by Apotex Corp., and CMS classifies it as a generic product.